BUSINESS

• Roche to Top Global Drug Maker Ranking in 2020, Consulting Firm Predicts
  June 16, 2016

• Merck Serono Can Catch Up with Rivals in Immuno-Oncology Space: Japan Oncology Head
  June 16, 2016

• Eisai’s Anti-Fractalkine Antibody Suggests Safety in RA
  June 15, 2016

• Sawai to Make 700 Factory Contractors Permanent Employees
  June 15, 2016

• SymBio Kicks Off Japan PIII for Patient-Controlled Pain Management Drug
  June 15, 2016

• PDUFA Date Set for Jan. 31, 2017 for Daiichi Sankyo’s Nausea Drug
  June 15, 2016

• Otsuka, Acucela End Partnership on AMD Drug after Trial Data Disappoint
  June 15, 2016

• Ethical Drug Sales Up 8.1% in April: Crecon Report
  June 14, 2016

• No Higher Mortality Risk Including CV Death Observed with Alogliptin against Placebo: Takeda
  June 14, 2016

• Dave Fredrickson Tapped as Next Chief of AstraZeneca Japan
  June 13, 2016

• Takeda Looks to Join Top 10 List in Global Oncology Space in 2025
  June 10, 2016

• FY2015 Earnings Roundup - 5: 10 Firms Unveil Mid-Term Biz Plans, Many Play It Safe
  June 10, 2016

• Mitsubishi Gas Chemical, Nippon Kayaku Form JV for Antibody, Biosimilar Production
  June 10, 2016

• Takeda Gets Worldwide Rights to Theravance’s GI Drug Candidate
  June 10, 2016

• Jacques Nathan to Lead Sanofi Japan from July 1
  June 10, 2016

• AZ Japan Pres. Baertschi to Become CEO of Grünenthal in October
  June 9, 2016

• Takeda, Ultragenyx Ink Strategic Partnership on Rare Genetic Diseases
  June 9, 2016

• Shionogi to Transfer 3 Off-Patent Cancer Drugs to Nichi-Iko
  June 9, 2016

• FY2015 Earnings Roundup - 4: Generic Biz Strategies Revolving around AG Launches
  June 9, 2016

• Kaketsuken Announces Plan for Production Restart, Says Flu Vaccine Output Will Be Lower
  June 9, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 468
• 469
• 470
• 471
• 472
• 473
• 474
• 475
• 476
• …
• Next ›
• 最終 »